View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Solid Cancers

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Axelar AB Presents the New Anticancer Agent AXL1717 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA

2009 NOV 23 ... future". Keywords: Anticancer Therapy, Clinical Trial Research, Oncology, Solid Cancers, Solid Carcinomas, Therapy, Treatment, Karolinska Development Ab. This ...

Subject: Cancer

Price: $3.00

Celsion Reports Third Quarter 2009 Financial Results and Business Update

2009 NOV 23 ... cancer is one of the most deadly forms of cancer and ranks as the fifth most common solid tumor cancer. The incidence of primary liver cancer is approximately 20,000 cases per ... an approved and frequently used oncology drug for the treatment of a wide range of cancers including breast cancer. Localized mild hyperthermia (40-42 degrees Celsius) releases ...

Subject: Celsion Corporation

Price: $3.00

For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility

2009 NOV 23 ... Drug Therapy, Male Infertility, Medical Device, Oncology, Pediatrics, Physiology, Solid Cancers, Solid Carcinomas, Surgery, Tissue Bank, The Children's Hospital of Philadelphia. ...

Subject: Pediatrics

Price: $3.00

Mersana Therapeutics Publishes Review Article Detailing Advantages of its Lead Cancer Compound in Journal of Advanced Drug Delivery Reviews

2009 NOV 23 ... Oncology, Parasympathomimetic, Polymer Therap, Prodrug, Radiation-Sensitizing Agent, Solid Cancers, Solid Carcinomas, Therapy, Topoisomerase, Treatment, Xenograft, Xenotransplantion, ...

Subject: Cancer

Price: $3.00

NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies

2009 NOV 23 ... Ovarian Carcinoma, Peripheral T-Cell Lymphoma, Prostate Cancer, Prostatic Neoplasms, Solid Cancers, Solid Carcinomas, Therapy, Treatment, U.S. Food and Drug Administration, Women's ...

Subject: Hematologic Disease

Price: $3.00

New data from Yale University illuminate research in hand-and-foot syndrome

2009 NOV 23 ... Leukopenia, Nausea, Oncology, Oxaliplatin, Pancreas, Pharmaceuticals, Pharmacogenetics, Solid Cancers, Solid Carcinomas, Stomatitis, Synthase, Therapy, Treatment, Vomiting, Yale University. ...

Subject: Hand-and-Foot Syndrome

Price: $3.00

New findings from Hokkaido University in the area of renal cell carcinoma therapy described

2009 NOV 23 ... Oncology, Pain Medicine, Pharmaceuticals, Renal Cell Cancer, Renal Cell Carcinoma, Solid Cancers, Solid Carcinomas, Surgery, Treatment. This article was prepared by Pain & ...

Subject: Renal Cell Carcinoma Therapy

Price: $3.00

Research by V.G. Oehler and colleagues in leukemia provides new insights

2009 NOV 23 ... Myeloid Leukemia, Oncology, Progenitor Cells, Proteins, Proteomics, Retinoic Acid, Solid Cancers, Solid Carcinomas, Stem Cell Research, Therapy, Treatment, Tyrosine Kinase. ...

Subject: Leukemia

Price: $3.00

Research from A. Grolleaujulius and co-researchers yields new findings on immunotherapy

2009 NOV 23 ... autologous DCs have been conducted in patients with a number of hematological and solid cancers, including malignant melanoma, lymphoma, myeloma, and non-small cell lung cancer. These ...

Subject: Immunotherapy

Price: $3.00

Research from A. Nagamitsu and colleagues provide new insights into solid cancer therapy

2009 NOV 23 ... cancer, cholangiocarcinoma, massive renal cell carcinoma, pancreatic and other abdominal solid cancers. This AT-induced hypertension resulted in remarkably enhanced tumor delivery accompanied ...

Subject: Solid Cancer Therapy

Price: $3.00

Research from Radboud University in the area of life sciences published

2009 NOV 23 ... New York, NY 10013-1917, USA. Keywords: Country:Netherlands, Life Sciences, Solid Cancers, Solid Carcinomas, Oncology, Pharmaceuticals, Drug Development, Therapy, Treatment, Drug ...

Subject: Life Sciences

Price: $3.00

Research on cancer published by scientists at University of Minnesota

2009 NOV 23 ... a compound with low micromolar cytotoxicity against a wide-range of hematologic and solid tumor cells. More excitingly, our studies of 5q in camptothecin (CCRF-CEM/C2) and ... concluded: "These results suggest that 5q is a promising candidate for treatment of cancers with multiple drug resistance." Das and colleagues published their study ...

Subject: Cancer

Price: $3.00

Researchers at Johns Hopkins University, Department of Pathology target leiomyosarcoma prognosis

2009 NOV 23 ... Baltimore, Leiomyosarcoma Prognosis, Behavior, Leiomyosarcoma, Oncology, Pathology, Solid Cancers, Solid Carcinomas, Urology. This article was prepared by Clinical Oncology ...

Subject: Leiomyosarcoma Prognosis

View Free
Daily News
Article

Scientists at Boston University discuss research in carcinoma therapy

2009 NOV 23 ... Protein Kinase Inhibitor, Pulmonology, Respiratory Infection, Seborrheic Dermatitis, Solid Cancers, Solid Carcinomas, Squamous Cell Carcinoma, Therapy, Treatment. This ...

Subject: Carcinoma Therapy

Price: $3.00

Studies from University of Pittsburgh yield new data on astrocytoma

2009 NOV 23 ... Biopsy, Brain Cancer, Brain Carcinoma, Neuro-Oncology, Oncology, Radiation Therapy, Solid Cancers, Solid Carcinomas, Surgery, Treatment, University of Pittsburgh. This ...

Subject: Astrocytoma

Price: $3.00

Study data from University of Paris update understanding of cancer

2009 NOV 23 ... Analog, Oncology, Pharmaceuticals, Pre-Trials Research, Radiation-Sensitizing Agent, Solid Cancers, Solid Carcinomas, Therapy, Treatment, University of Paris. This article ...

Subject: Cancer

Price: $3.00

Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer

2009 NOV 23 ... Pre-Trials Research, Prostate Cancer, Prostate-Specific Antigen, Prostatic Neoplasms, Solid Cancers, Solid Carcinomas, Therapies, Therapy, Treatment, Tokai Pharmaceuticals. ...

Subject: Tokai Pharmaceuticals

Price: $3.00

Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology

2009 NOV 23 ... Gynecology, Human Papilloma Virus, Infectious Diseases, Oncology, Papilloma, Solid Cancers, Solid Carcinomas, Viral Research, Virology, Xenomics Inc. This article was ...

Subject: Xenomics, Inc.

Price: $3.00

ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society

2009 NOV 23 ... is a novel organic arsenic being developed for the treatment of various hematologic and solid cancers. Preclinical and clinical studies to date have demonstrated that darinaparsin is ...

Subject: ZIOPHARM Oncology, Inc.

Price: $3.00

ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress

Subject: ZIOPHARM Oncology, Inc.

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx